Apretude 600 mg prolonged-release suspension for injection

Licence status
Authorised: 15/09/2023
Active substances
Cabotegravir Sodium, cabotegravir
Dosage Form
Film-coated tablet
Licence number
EU/1/23/1760/001
Licence holder
ViiV Healthcare BV

Product documents

Licence information

ATC code
J05AJ04 cabotegravir
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
15/09/2023